PRESCRIPTION DRUG PRICING REDUCTION ACT; Congressional Record Vol. 165, No. 205
(Senate - December 18, 2019)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Page S7123]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                PRESCRIPTION DRUG PRICING REDUCTION ACT

  Mr. GRASSLEY. Madam President, Senator Wyden and I received a letter 
from the Michael J. Fox Foundation for Parkinson's Research. Their 
letter endorsed our bipartisan Prescription Drug Pricing Reduction Act, 
which tries to respond to what we are hearing from our constituents 
about the public outrage over the big increases in prescription drugs.
  Now, it happens with Parkinson's disease that about 1 million 
Americans have it, and it seems like up to now there is no way to stop 
it or cure it, but thanks to modern medicine, the symptoms can be 
treated to help patients live a much better life.
  Ninety percent of all individuals diagnosed with Parkinson's disease 
are on Medicare. Our bill, the bill to reduce prescription drug prices, 
would help these seniors afford their medicine with a cap on out-of-
pocket expenses. In other words, they would know at the beginning of 
the year that they only have to spend x number of dollars on drugs, no 
more.
  Of course, this brings me to what Congress should be doing. Congress 
needs to act, not only for those with Parkinson's disease, but for all 
Americans who need our help.
  I yield the floor.
  I suggest the absence of a quorum.
  The PRESIDING OFFICER. The clerk will call the roll.
  The legislative clerk proceeded to call the roll.
  Mr. DURBIN. Madam President, I ask unanimous consent that the order 
for the quorum call be rescinded.
  The PRESIDING OFFICER. Without objection, it is so ordered.

                          ____________________